Veltassa (patiromer) is a prescription medication used to treat hyperkalemia, a condition where potassium levels in the blood are too high. It works by binding to potassium in the gut and removing it through stool, helping bring levels back into a safe range. Veltassa is not meant for emergency situations where dangerously high potassium needs to be corrected immediately, because it takes several hours to start working.
Why High Potassium Needs Treatment
Potassium plays a critical role in how your heart beats and your muscles contract. When blood levels climb too high, it can cause muscle weakness, numbness, heart palpitations, and in severe cases, life-threatening changes to heart rhythm. Hyperkalemia is especially common in people with chronic kidney disease, because the kidneys are responsible for filtering excess potassium out of the blood. Certain medications, particularly a class of blood pressure and heart failure drugs that block a hormone called aldosterone, can also push potassium levels up.
This is where Veltassa fits in. For people who need to stay on those heart or kidney medications but keep running into high potassium as a side effect, Veltassa can lower potassium enough to let them continue their other treatments safely.
How Veltassa Works
Veltassa is a powder that you mix with water and drink. It’s a polymer, meaning it’s a large molecule that your body never absorbs. Instead, it travels through your digestive tract and reaches the large intestine, where it swaps calcium ions for potassium ions. The potassium binds to the polymer, gets trapped, and leaves your body in stool rather than being reabsorbed into the bloodstream.
This exchange process takes time. Veltassa’s onset of action is 4 to 7 hours after you take it, which is why it’s suited for ongoing management of high potassium rather than acute emergencies.
What to Expect When Taking It
The most common side effects are digestive. In clinical trials, constipation affected about 7% of patients, diarrhea about 5%, and nausea, abdominal discomfort, and gas each around 2%. These are generally mild and manageable.
One side effect worth knowing about is low magnesium, which occurred in about 5% of patients in studies. Because Veltassa can bind magnesium in addition to potassium, your doctor will monitor your magnesium levels and may recommend a supplement if they drop too low.
You’ll also need regular blood tests to track your potassium levels, especially early on. Your dose may be adjusted at intervals of one week or longer based on those results.
Timing With Other Medications
Because Veltassa binds to many substances in the gut, it can interfere with the absorption of other oral medications you take. The general rule is to take any other oral medication at least 6 hours before or 6 hours after your dose of Veltassa. If that kind of separation isn’t realistic with your schedule, you and your prescriber may need to choose one or the other for that dosing window. This is one of the more practical challenges of using Veltassa, so it’s worth mapping out a daily schedule that works.
Who Should Avoid Veltassa
Veltassa is contraindicated if you’ve had an allergic reaction to it or any of its ingredients. It should also be avoided in people with severe constipation, bowel obstruction, or impaction, including those recovering from surgery who have slowed bowel motility. Because Veltassa relies on moving through the intestines to do its job, anything that stalls that transit can make it both ineffective and potentially harmful to the gut.
How Veltassa Compares to Lokelma
Lokelma (sodium zirconium cyclosilicate) is the other modern potassium binder on the market, and the two medications differ in a few practical ways. Lokelma works faster, with an onset of action within about 1 hour compared to Veltassa’s 4 to 7 hours. On the other hand, Lokelma contains a significant amount of sodium, which can be a concern for people managing fluid retention or heart failure. Veltassa uses calcium as its exchange ion instead, avoiding that sodium load.
Both are considered much more tolerable than older potassium binders like calcium polystyrene sulfonate, which was notorious for being unpleasant to take and carried a risk of serious gastrointestinal side effects. The choice between Veltassa and Lokelma often comes down to how quickly potassium needs to come down, whether sodium intake is a concern, and how easily the dosing schedule fits with other medications.